In October, when GSK agreed to a $2.2 billion settlement to resolve approximately 80,000 lawsuits | With a $2.2 billion ...

GSK Plc American depositary receipts (ADRs) sank in intraday trading Monday after a Delaware judge allowed lawsuits to ... in December 2022.” Along with GSK, Zantac has been owned by several ...

GSK has opted to settle a key lawsuit in its defence against ... including a US federal court ruling in December 2022 that found no reliable evidence that Zantac causes the alleged injuries ...

Shares in GSK fell around 9% this morning after a judge in a Delaware court gave the green light for tens of thousands of lawsuits claiming harm by gastrointestinal drug Zantac to proceed to trial.

U.S regulators pulled the drug from shelves the next year, and as fears over lawsuits and ... couple days in August 2022.

Tens of thousands of cancer-stricken patients filed personal injury and product liability lawsuits ... s liability to Zantac users. The truth began to emerge on August 10, 2022, when a Deutsche ...

While we don't have an exact timeline for when payouts are expected to begin, we are nonetheless offering funding for Zantac plaintiffs while they wait." To apply for a cash advance lawsuit loan ...

Today, prominent investor rights law firm Bernstein Litowitz Berger & Grossmann LLP (“BLB&G”) filed a class action lawsuit ... to Zantac users. The truth began to emerge on August 10, 2022 ...